AFJK on Nasdaq
Aimei Health Technology Co., Ltd.
Price unavailable
Last updated Oct 16, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Financial statements
Every line of the income statement in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| General, administrative and operational costs | -$835.8K | -$1.1M |
| Loss from operations | -$835.8K | -$1.1M |
| Interest earned on cash held in trust | $1.9M | $3.6M |
| Total other income, net | $1.9M | $3.6M |
| NET INCOME | $1.1M | $2.6M |
Every line of the balance sheet in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash | $2.9K | $28.2K | |
| Prepaid expenses | $2.2K | ||
| Total current assets | $2.9K | $30.4K | |
| Cash held in Trust Account | $12.1M | $73.8M | |
| TOTAL ASSETS | $12.1M | $73.8M | |
| Accrued expenses | $448.0K | $299.5K | |
| Extension loans related party | $2.0M | $227.7K | |
| Due to a related company | $899.6K | $289.8K | |
| Total current liabilities | $3.4M | $817.0K | |
| Deferred underwriter fee payable | $690.0K | $690.0K | |
| TOTAL LIABILITIES | $4.1M | $1.5M | |
| Ordinary shares, subject to possible redemption. 1,040,332 and 6,900,000 shares issued and outstanding at redemption value of $11.63 and $10.69 as of December 31, 2025 and 2024, respectively | $12.1M | $73.8M | |
| Ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 2,126,000 and 2,126,000 shares issued and outstanding as of December 31, 2025 and 2024, respectively (excluding 1,040,332 and 6,900,000 shares subject to possible redemption, respectively) | $213 | $213 | |
| Accumulated deficit | -$4.1M | -$1.5M | |
| Total shareholders deficit | -$4.1M | -$1.5M | -$134.1K |
| TOTAL LIABILITIES, TEMPORARY EQUITY AND SHAREHOLDERS DEFICIT | $12.1M | $73.8M | |
| Temporary equity, shares issued | 1.0M shares | 6.9M shares | |
| Temporary equity, shares outstanding | 1.0M shares | 6.9M shares | |
| Temporary equity, redemption value | $11.63 | $10.69 | |
| Ordinary shares, par value | $0.00 | $0.00 | |
| Ordinary shares, shares authorized | 500.0M shares | 500.0M shares | |
| Ordinary shares, shares issued | 2.1M shares | 2.1M shares | |
| Ordinary shares, shares outstanding | 2.1M shares | 2.1M shares | |
| Ordinary shares subject to possible redemption | 1.0M shares | 6.9M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net income | $1.1M | $2.6M |
| Interest earned on cash held in trust | -$1.9M | -$3.6M |
| Prepaid expenses | $2.2K | -$2.2K |
| Due to a related company | $120.0K | $120.0K |
| Accrued expenses | $148.5K | $274.7K |
| Net cash used in operating activities | -$565.1K | -$672.3K |
| Cash withdrawn from Trust Account in connection with redemption | $65.3M | |
| Extension payments deposited in Trust Account | -$1.7M | -$277.7K |
| Net cash provided by (used in) investing activities | $63.6M | -$277.7K |
| Proceeds from extension promissory note related party | $1.7M | $277.7K |
| Advance from related party | $539.8K | $119.8K |
| Redemption of ordinary shares | -$65.3M | |
| Net cash provided by (used in) financing activities | -$63.0M | $397.5K |
| NET CHANGE IN CASH | -$25.3K | -$552.5K |
| Remeasurement of ordinary shares subject to possible redemption | $1.9M | $3.6M |
| Extension funds attributable to ordinary shares subject to redemption | $1.7M | $277.7K |
Compare Aimei Health Technology Co., Ltd. with another company
Recent filings
- Oct 9, 2026PRE 14A
- Oct 5, 20268-K
- Sep 3, 20268-K
- Aug 25, 20268-K
- Aug 13, 202610-Q
- Aug 10, 2026SCHEDULE 13G/A
- Aug 6, 20268-K
- Aug 5, 2026SCHEDULE 13G/A
- Jul 8, 20268-K
- Jul 6, 20268-K
- Jul 1, 20263
- Jun 29, 20268-K
- Jun 16, 202610-Q
- Jun 4, 20268-K
- May 20, 20268-K
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6